Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Enterprise Value (2016 - 2025)

BioCorRx's Enterprise Value history spans 16 years, with the latest figure at $432656.0 for Q3 2025.

  • For Q3 2025, Enterprise Value rose 351.71% year-over-year to $432656.0; the TTM value through Sep 2025 reached $432656.0, up 351.71%, while the annual FY2024 figure was -$322845.0, 66.37% down from the prior year.
  • Enterprise Value for Q3 2025 was $432656.0 at BioCorRx, up from -$500899.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at $432656.0 in Q3 2025 and bottomed at -$2.0 million in Q1 2021.
  • The 5-year median for Enterprise Value is -$269311.0 (2025), against an average of -$377701.8.
  • The largest YoY upside for Enterprise Value was 351.71% in 2025 against a maximum downside of 224.13% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$203676.0 in 2021, then rose by 4.81% to -$193872.0 in 2022, then fell by 0.09% to -$194056.0 in 2023, then crashed by 66.37% to -$322845.0 in 2024, then soared by 234.01% to $432656.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Enterprise Value are $432656.0 (Q3 2025), -$500899.0 (Q2 2025), and -$269311.0 (Q1 2025).